Advertisement

Topics

Companies Related to "Safety and Tolerability of Etanercept in Alzheimer's Disease" [Most Relevant Company Matches] RSS

01:17 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Tolerability of Etanercept in Alzheimer's Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Tolerability Etanercept Alzheimer Disease" Companies 1–25 of 4,000+

Relevant

Enbrel® (etanercept)

Enbrel® (etanercept) is a TNF inhibitor approved for the following indications: moderately to severely active rheumatoid arthritis, polyarticular-course juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (arthritis of the spine) and psoriasis.


Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer's, to discover a cure, and to improve the lives of people with the disease. Nobel laureate Dr. Paul Greengard directs the Foundation's team of internationally renowned scientists, who have been at th...

Alzheimer's Research and Prevention Foundation

The Alzheimer's Research and Prevention Foundation (ARPF) is a non-profit organization dedicated to reducing the incidence of Alzheimer's disease by conducting clinical research and providing educational outreach about the lifestyle changes that can help prevent Alzheimer's disease. For more information, please visit the Alzheimer's Research and Prevention Foundation at www.alzheimersprevention.o...


Alzheimer’s Association, New York City Chapter

Alzheimer’s disease is one of the nation’s largest public health crises. It is the fifth leading cause of death in California and the only leading cause of death that cannot be prevented, cured or even slowed. 630,000 people in California are currently living with Alzheimer’s disease, and more than 1.6 million Californians provide unpaid care for ...

Alzheimer's Foundation International

The Alzheimer's Foundation International (AFI) is working toward collaboratively setting a paradigm of quality care for individuals with the disease and their families by raising awareness of Alzheimer's disease and related dementias, providing education, and establishing programs and services that can be replicated in countries around the globe. Currently, AFI's member organizations are the Alzhe...

The Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more informatio...

EXPERT BIOMED, INC

Expert BioMed offers a service to pharmaceutical companies providing screening of potential drugs on Alzheimer's disease cell and animal models designed and maintained in the company and data interpretation service in addition to the Expert BioMed systems and platform for new drug development. Expert BioMed offers new monoclonal and polyclonal antibodies, recombinant proteins and peptides as bioma...

Arizona Alzheimer's Consortium

The Arizona Alzheimer's Consortium is a laboratory without walls designed to leverage the strengths of its seven member institutions to promote the scientific understanding of Alzheimer's disease. The Consortium is attacking Alzheimer's disease by combining breakthroughs in genomic medicine and cutting-edge research with data from sophisticated brain imaging programs and advanced clinical trials t...

Alzheon Inc.

Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodru...

The Alzheimer’s Association

The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Its mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Learn more ...

Avid Radiopharmaceuticals

Founded in 2004, Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. Two of Avid's radiopharmaceuticals are already in clinical trials, and Avid intends to make these products available to pharmaceutical companies that are seeking to develop new drugs for treatment of Alzheime...

Ebixa

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in ...

Janssen Alzheimer Immunotherapy

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities, such as bathing and eating. As AD progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, delusion...

Alzheimer's Drug Discovery Foundation

The ADDF is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. Since 1998, the ADDF has granted more than $40 million to fund over 295 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 15 countries.

Alzheimer's Drug Discovery Foundation (ADDF)

Alzheimer's Drug Discovery Foundation (http://www.alzdiscovery.org/) is the only public charity whose sole mission is to fund drug discovery and development to prevent, treat, and cure Alzheimer's disease and cognitive aging. An affiliated public charity of the Institute for the Study of Aging (ISOA), a private foundation established by the Estee Lauder family in 1998, ADDF was established in 2004...

Axonyx

Axonyx is a biopharmaceutical company focused on the acquisition and development of proprietary products and technologies for the treatment and diagnosis of Alzheimer's Disease and other memory-related cognitive disorders including prion diseases such as Mad Cow Disease. After completion of a Phase II Proof of Concept clinical study in October of 2001 for Phenserine, Axonyx's lead product for Alzh...

Beta Amyloid Org

Beta Amyloid.org keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is to provide anything and everything to the researchers at one website. Beta Amyloid.org access is totally free; however, we don’t endorse any scientific information. Our team of scientists, editors an...

Alzheimer’s Greater Los Angeles

Alzheimer’s Greater Los Angeles (formerly known as Alzheimer’s Association, California Southland Chapter) provides programs and services free of charge to individuals with Alzheimer’s and related dementias, their families, caregivers and the community. Low cost training and education are also offered for professionals. Alzheimer’s Great...

EXPERT BIOMED

Expert BioMed, Inc. is a privately-held biotechnology R&D company. The company focus is the development of prevention, diagnostic and therapy strategies to combat the Alzheimer's disease. In the Expert BioMed, Alzheimer cell and animal models and a set of monoclonal and polyclonal antibodies directed to new Alzheimer marker have been developed. The new diagnostic test for early cancer detection is...

Catabasis Pharmaceuticals Inc.

Catabasis is a clinical-stage company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases. The company's drug development programs are based on the principles of pathway pharmacology, the treatment of diseases by simultaneously modulating multiple targets in a disease pathway. Using its proprietar...

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...

Alzheimer's Disease International

SOURCE Alzheimer's Disease International

AFFiRiS AG

On the basis of the company's own patents, AFFiRiS develops tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease hypertension and four other conditions with an urgent medical requirement and attractive market volumes. Alzheimer's is currently the most advanced project, with two potential products having just completed the phase I clinical studies. In O...

Diagnostic Potentials Ltd

Diagnostic Potentials Ltd is developing a range of diagnostic and monitoring systems for Central Nervous system (CNS) disease states. The first product that has been developed is a system for the early diagnosis of Alzheimer's Disease that will enable clinical consultants to make a positive decision on the care of the patient and on the prescribing of drugs.CNS disorders, such as Alzheimer's, Park...

Alzheimer’s Orange County

Alzheimer’s Orange County provides programs and services, free of charge, to Orange County residents with Alzheimer’s and related dementia disorders, their families, caregivers, and the community. Alzheimer’s Orange County began as an independent 501c3 nonprofit in 1982, became a chapter of the national Alzheimer’s Association in 1984, and in ...


More From BioPortfolio on "Safety and Tolerability of Etanercept in Alzheimer's Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks